CO2 lasers
News
20.04.2016
The sun, the main cause of occupational cancer
Brussels, Belgium/Lugano Switzerland – There are almost 14.5 million workers in Europe, who spend at least 75% of their working time under the sun. A new report published last week […]
10.12.2019
Asclepion Laser Technologies: Steady growth enables investment in the future
On September 9, an extension to the main building of Asclepion Laser Technologies GmbH was inaugurated and the usable floor space almost doubled by a further 2,500 m2 during a […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]